Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Type

Guidance programme

Advice programme

Showing 1 to 6 of 6

TitleReference numberPublishedLast updated
Danicopan with ravulizumab or eculizumab for treating paroxysmal nocturnal haemoglobinuriaTA1010
Eculizumab for treating relapsing neuromyelitis optica (terminated appraisal)TA647
Eculizumab for treating refractory myasthenia gravis (terminated appraisal)TA636
C3 glomerulopathy in the native kidney: eculizumabESUOM49
Prevention of recurrence of C3 glomerulopathy post-transplant: eculizumabESUOM44
Eculizumab for treating atypical haemolytic uraemic syndromeHST1

Results per page

  1. 10
  2. 25
  3. 50
  4. All